Abstract:Objective: To asses the correlation of data derived from dual-layer (DL)-CT material-maps and breast MRI data with molecular biomarkers in invasive breast carcinomas. Methods: All patients at the University Breast Cancer Center who underwent a clinically indicated DLCT-scan and a breast MRI for staging of invasive ductal breast cancer from 2016 to 2020 were prospectively included. Iodine concentration-maps, and Zeffective-maps were reconstructed from the CT-datasets. T1w- and T2w-signal intensities, ADC and the clustered shapes of the dynamic-curves (washout, plateau, persistent) were derived from the MRI-datasets. ROI-based evaluations of the cancers and the reference "musculature" were performed semi-automatically in identical anatomical positions using dedicated evaluation software. Statistical analysis was essentially descriptive using Spearmańs rank correlation and (multivariable) partial correlation. Results: The signal intensities measured in the 3rd phase of the contrast dynamics correlated at an intermediate level of significance with the iodine content and the Zeffective-values derived from the breast target lesions (Spearmańs rank correlation-coefficient r = 0.237/0.236, p = 0.002/0.003). The bivariate and the multivariate analyses displayed correlations of an intermediate significance level of the iodine content and the Zeff-values measured in the breast target lesions with immunhistochemical subtyping (r = 0.211-0.243, p = 0.002-0.009, respectively). The Zeff-values showed the strongest correlations when normalized to the values measured in the musculature and in the aorta (r = -0.237 to -0.305, r=<0.001-0.003). The MRI-assessments showed correlations of intermediate to high significance and low to intermediate significance between the ratios of the T2w-signal intensities and the trends of the dynamic curves measured in the breast target lesions and in musculature and immunohistochemical cancer subtyping, respectively (T2w: r = 0.232-0.249, p = 0.003/0.002; dynamics: r = -0.322/-0.245, p=<0.001/0.002). The ratios of the clustered trends of the dynamic curves measured in the breast target lesions and in musculature correlated with tumor grading on intermediate significance level (r = -0.213 and -0.194, p = 0.007/0.016) and with Ki-67 on a low significance level (bivariate analysis: r = -0.160, p = 0.040). There was only a weak correlation between the ADC-values measured in the breast target lesions and HER2-expression (bivariate ansalysis: r = 0.191, p = 0.030). Conclusions: Our preliminary results indicate that evaluation of perfusion based DLCT-data and MRI-biomarkers show correlations with the immunhistochemical subtyping of invasive ductal breast carcinomas. Further clinical research is warranted in order to validate the value of the results and define clinical situations in which the use of the described DLCT-biomaker and MRI biomarkers may be helpful in clinical patient care.

Correlation Between Clinicopathological Characteristics and Convergence Symptom in Patients with Breast Infiltrating Ductal Carcinoma

Clinicopathological Features of Breast Cancer Progression: from DCIS to Invasive Ductal Carcinoma

Correlation Analysis between Expression Profiles of Molecular Markers and Contrast-Enhanced Ultrasound Parameters in Breast Cancer

Expressions of Progesterone Receptor a and B in Breast Invasive Ductal Carcinoma and Their Clinical Significance

The X-ray Features of Breast Ductal Carcinoma in Situ and Its Small Invasive Foci and Correlation Between Mammographic Features and Prognostic Biologic Factors

Expressions of biomarkers in breast ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) and their relationship with sonographic features

HER2 Overexpression in Ductal Carcinoma in Situ is Associated with Ipsilateral Breast Cancer Recurrence after Conservative Surgery

The value of semiquantitative parameters of DCE-MRI in predicting and monitoring efficacy of concurrent chemoradiotherapy in laryngeal and hypopharyngeal carcinoma

Diagnostic evaluation of ductal carcinoma in situ of the breast: ultrasonographic, mammographic and histopathologic correlations

The correlation between ultrasonographic findings and pathologic features in breast cancers

New Exploration of the Correlation between Sonographic and Pathological Features of Ductal Carcinoma in Situ and Invasive Ductal Carcinoma

Clinical/Prognostic Significance of Syndecan-1 Expression in Invasive Breast Carcinoma with Distant Metastasis and Its Correlation with Tumor Immunity

Prognostic value of ductal carcinoma in situ component in invasive ductal carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis.

Pathological Underestimation and Biomarkers Concordance Rates in Breast Cancer Patients Diagnosed with Ductal Carcinoma in Situ at Preoperative Biopsy

The Correlation of Quantitative and Semi-Quantitative Parameters Obtained from Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Histopathology in Human Breast Cancer

Laryngeal and Hypopharyngeal Squamous Cell Carcinoma: Association Between Quantitative Parameters Derived from Dual-Energy CT and Histopathological Prognostic Factors

Invasive Ductal Carcinoma with Coexisting Ductal Carcinoma in Situ (IDC/DCIS) Versus Pure Invasive Ductal Carcinoma (IDC): a Comparison of Clinicopathological Characteristics, Molecular Subtypes, and Clinical Outcomes

Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer

Correlation Between Conventional Ultrasound Features Combined with Contrast-Enhanced Ultrasound Patterns and Pathological Prognostic Factors in Malignant Non-Mass Breast Lesions.

The Prognostic Significance of Co-Existence Ductal Carcinoma in Situ in Invasive Ductal Breast Cancer: a Large Population-Based Study and a Matched Case-Control Analysis

Intermodal correlation of quantitative CT-data and MRI-biomarkers derived from synchronous spectral CT-maps and breast MRI-examinations with molecular biomarkers in invasive ductal breast carcinomas